I have heard concerns from my constituents that some drug plans have what I refer to as a Fail First Policy in which a beneficiary may be prescribed a more expensive medication but first has to use a lower cost drug or a plan-preferred medication.
Senator Collins discusses issues with drug plans and their policies affecting beneficiaries.
Share
More from Susan Collins
Alzheimer’s is one of the greatest public health challenges of our time, affecting more than seven million Americans, including more than 29,000 people in Maine.
I was pleased that the bill prevents the OMB from implementing its proposed rule, which would politicize grants and harm small, rural communities, families, and biomedical research.
Other voices in this conversation
